Plunkett Research Online: Biomark Diagnostics

BIOMARK DIAGNOSTICS (BUX:CNQ) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor and assess early treatment for cancer. Its research and .....



Biomark Diagnostics
Ticker: BUX
Exchange: CNQ
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 604 836-6950
Fax:
Address: 165 - 10551 Shellbridge Way
Richmond, BC V6X 2W8 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Medical Laboratories
ContactsDescription

Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor and assess early treatment for cancer. Its research and .....See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: